Search Results - Retina Today

January/February 2026 | Features

Methotrexate: An Emerging Surgical Adjuvant

This drug is proving useful for improving outcomes in many retinal pathologies.

Alan J. Franklin, MD, PhD; Lauren Gibson Snellings, MD; Aly Nguyen, MD, MS; and Christopher D. Riemann, MD

May/June 2024 Supplement

Geographic Atrophy: Options in Clinical Therapy

David RP Almeida, MD, MBA, PhD, DABO, FRCSC, FASRS; Lisa J. Faia, MD; and Christopher D. Riemann, MD

October 2019 | Features

Blast From the Past: The Rebirth of Dual-Bore Cannulas

Modification of a device invented by a trailblazer of retina surgery gives surgeons a new option in the OR.

Christopher D. Riemann, MD

November/December 2018

The Best of Eyetube 2018

The authors share their top 10 surgical retina videos and explain why each one is worthy of a look.

David Xu, MD, and Michael A. Klufas, MD

November/December 2017

The Birth of a New 3-D Viewing System

A do-it-yourself ethos—and a lack of commercial availability—drove this ophthalmologist to design his own system.

Gustavo Hüning, MD, MBA, DiSSO; with Arthur Hüning, MD; Affonso Hüning, MD; and Lair Hüning, MD, MSc, MBA

January/February 2012

Letters

July/August 2011

SURGICAL UPDATES: The Next Generation Machines for Modern Vitrectomy

A candid, tell-it-like-it-is review of the available systems.

JOHN KITCHENS, MD FOR CHRISTOPHER RIEMANN, MD; DEREK KUNIMOTO, MD, JD; JORGE FORTUN, MD; THOMAS ALBINI, MD; AND ROSS LAKHANPAL, MD; AND THE VIT-BUCKLE SOCIETY

January 2011

Initial Impressions With 27-gauge Vitrectomy

The first generation of a new surgical modality shows promise.

Christopher D. Riemann, MD

October 2010 Insert

DSPs = Predictability, Reliability, and Performance in Retina Surgery

Christopher D. Riemann,MD - Cincinnati Eye Institute

November 2007

OCT After Intravitreal Anti-VEGF Therapies for AMD

A quantitative comparison of intravitreal ranibizumab, bevacizumab, and pegaptanib.

SriniVas R. Sadda, MD, Christopher D. Riemann, MD

November 2007

OCT After Intravitreal Anti-VEGF Therapies for AMD

A quantitative comparison of intravitreal ranibizumab, bevacizumab, and pegaptanib.

SriniVas R. Sadda, MD, Christopher D. Riemann, MD

November 2007

Vitreoretinal Surgeons Pick up Endoscopes

The endoscope has become a key tool in modern microincisional and minimally invasive diagnostic and therapeutic modalities.

Christopher D. Riemann, MD

November 2007

Vitreoretinal Surgeons Pick up Endoscopes

The endoscope has become a key tool in modern microincisional and minimally invasive diagnostic and therapeutic modalities.

Christopher D. Riemann, MD